Search details
1.
Final 3-year clinical outcomes following transcatheter aortic valve implantation with a supra-annular self-expanding repositionable valve in a real-world setting: Results from the multicenter FORWARD study.
Catheter Cardiovasc Interv
; 99(1): 171-178, 2022 01 01.
Article
in English
| MEDLINE | ID: mdl-34331844
2.
Frailty, malnutrition, and the endocrine system impact outcome in patients undergoing aortic valve replacement.
Catheter Cardiovasc Interv
; 99(1): 145-157, 2022 01 01.
Article
in English
| MEDLINE | ID: mdl-34143555
3.
Percutaneous trans-axilla transcatheter aortic valve replacement.
Heart Vessels
; 37(10): 1801-1807, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-35505257
4.
Association of heart failure duration with clinical outcomes after transcatheter mitral valve repair for functional mitral regurgitation.
Catheter Cardiovasc Interv
; 98(3): E412-E419, 2021 09.
Article
in English
| MEDLINE | ID: mdl-33210823
5.
Comparison of a Complete Percutaneous Versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results From the Randomized SURTAVI Trial.
Circulation
; 140(16): 1296-1305, 2019 Oct 15.
Article
in English
| MEDLINE | ID: mdl-31476897
6.
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.
N Engl J Med
; 376(14): 1321-1331, 2017 04 06.
Article
in English
| MEDLINE | ID: mdl-28304219
7.
TAVR outcome after reclassification of aortic valve stenosis by using a hybrid continuity equation that combines computed tomography and echocardiography data.
Catheter Cardiovasc Interv
; 96(4): 958-967, 2020 10 01.
Article
in English
| MEDLINE | ID: mdl-32190961
8.
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO-3 randomized trial.
Catheter Cardiovasc Interv
; 93(7): 1374-1381, 2019 Jun 01.
Article
in English
| MEDLINE | ID: mdl-31116908
9.
Opportunistic Computed Tomography Imaging for the Assessment of Fatty Muscle Fraction Predicts Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement.
Circulation
; 141(3): 234-236, 2020 01 21.
Article
in English
| MEDLINE | ID: mdl-31958246
10.
Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement.
Am Heart J
; 170(4): 821-9, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26386807
11.
Outcomes and predictors of mortality after transcatheter aortic valve implantation: results of the Brazilian registry.
Catheter Cardiovasc Interv
; 85(5): E153-62, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25510532
12.
Outcome in TAVI patients with symptomatic aortic stenosis not fulfilling PARTNER study inclusion criteria.
Catheter Cardiovasc Interv
; 86(6): 1097-104, 2015 Nov 15.
Article
in English
| MEDLINE | ID: mdl-26032437
13.
The Year in Cardiology 2013: valvular heart disease (focus on catheter-based interventions).
Eur Heart J
; 35(8): 490-5, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24385378
14.
Initial clinical experience with the Coherex FlatStent™ and FlatStent™ EF PFO closure system for in-tunnel PFO closure: results of the Coherex-EU study.
Catheter Cardiovasc Interv
; 83(7): 1135-43, 2014 Jun 01.
Article
in English
| MEDLINE | ID: mdl-22815250
15.
Transcatheter aortic valve implantation through a diseased left common carotid artery: combined approach with endarterectomy and left carotid-subclavian bypass.
Catheter Cardiovasc Interv
; 81(4): 618-22, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-22887634
16.
Two-year outcomes after deployment of XIENCE V everolimus-eluting stents in patients undergoing percutaneous coronary intervention of bifurcation lesions: a report from the SPIRIT V single arm study.
Catheter Cardiovasc Interv
; 82(3): E163-72, 2013 Sep 01.
Article
in English
| MEDLINE | ID: mdl-23225766
17.
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trial.
Catheter Cardiovasc Interv
; 82(7): 1039-47, 2013 Dec 01.
Article
in English
| MEDLINE | ID: mdl-23592567
18.
First clinical experience with Celt ACD(®) : a femoral arterial puncture closure device.
J Interv Cardiol
; 26(4): 417-24, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23941656
19.
Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies.
J Thromb Thrombolysis
; 35(4): 483-93, 2013 May.
Article
in English
| MEDLINE | ID: mdl-23553245
20.
Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation.
Eur Heart J
; 33(12): 1459-68, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22285582